Table 2 Irritable bowel syndrome (IBS) diagnosis and risk of Parkinson’s disease (PD), nationwide case-control analysis.

From: Irritable bowel syndrome and Parkinson’s disease risk: register-based studies

 

PD cases

Controls

Model 1a

Model 2b

 

N

N

OR (95% CI)

OR (95% CI)

Non-IBS

56,311 (99.6)

1,691,716 (99.7)

1

1

IBS

253 (0.4)

5204 (0.3)

1.46 (1.29–1.66)

1.44 (1.27–1.63)

Years before index date

<5

93 (0.2)

2105 (0.1)

1.33 (1.08–1.64)

1.31 (1.06–1.61)

≥5

160 (0.3)

3099 (0.2)

1.55 (1.32–1.82)

1.53 (1.30–1.79)

<10

166 (0.3)

3331 (0.2)

1.50 (1.28–1.75)

1.47 (1.26–1.72)

≥10

87 (0.2)

1873 (0.1)

1.40 (1.13–1.73)

1.38 (1.11–1.71)

Age at IBS diagnosis, years

<50

28 (0)

766 (0)

1.10 (0.75–1.60)

1.09 (0.74–1.58)

≥50

225 (0.4)

4438 (0.3)

1.52 (1.33–1.74)

1.50 (1.31–1.72)

Stratified by sex

Male

89 (0.2)

1789 (0.1)

1.49 (1.21–1.85)

1.47 (1.19–1.82)

Female

164 (0.3)

3415 (0.2)

1.44 (1.23–1.69)

1.42 (1.22–1.67)

Stratified by age on the index date, years

<70

80 (0.1)

1538 (0.1)

1.57 (1.25–1.96)

1.55 (1.24–1.94)

70–79

101 (0.2)

2184 (0.1)

1.39 (1.14–1.70)

1.36 (1.12–1.67)

≥80

72 (0.1)

1482 (0.1)

1.46 (1.15–1.85)

1.44 (1.13–1.82)

  1. aConditional on birth year and sex.
  2. bAdditionally adjusted for country of birth, highest achieved education, chronic obstructive pulmonary disease (COPD), comorbidity index.